IDBS and Alchemi partner to accelerate biopharma regulatory filings with compliant AI agents
IDBS and Alchemi have partnered to connect Alchemi’s AI agents to governed data in IDBS Polar, enabling biopharma teams to produce CMC reports and submission dossiers faster—with 21 CFR Part 11 compliance and human review maintained throughout.